N-[(1-methyl-6-oxo-3-pyridinyl)methyl]-3-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyridazin-3-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyridazin-4-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyrimidin-2-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyrimidin-5-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide
C92H93N29O6 — CID 158522382
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1-methyl-6-oxo-3-pyridinyl)methyl]-3-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyridazin-3-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyridazin-4-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyrimidin-2-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyrimidin-5-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide
N-[(1-methyl-6-oxo-3-pyridinyl)methyl]-3-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyridazin-3-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyridazin-4-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyrimidin-2-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyrimidin-5-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide (PubChem CID 158522382) has the molecular formula C92H93N29O6 and a molecular weight of 1700.95 g/mol. Its IUPAC name is N-[(1-methyl-6-oxo-3-pyridinyl)methyl]-3-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyridazin-3-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyridazin-4-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyrimidin-2-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyrimidin-5-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide.
Molecular Properties
| Compound Name | N-[(1-methyl-6-oxo-3-pyridinyl)methyl]-3-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyridazin-3-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyridazin-4-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyrimidin-2-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyrimidin-5-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide |
|---|---|
| PubChem CID | 158522382 |
| Molecular Formula | C92H93N29O6 |
| Molecular Weight | 1700.95 g/mol |
| Exact Mass | 1699.79 |
| IUPAC Name | N-[(1-methyl-6-oxo-3-pyridinyl)methyl]-3-phenyl-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyridazin-3-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyridazin-4-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyrimidin-2-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide;3-phenyl-N-(pyrimidin-5-ylmethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxamide |
| SMILES | Cn1cc(CNC(=O)N2CCc3[nH]nc(-c4ccccc4)c3C2)ccc1=O.O=C(NCc1cccnn1)N1CCc2[nH]nc(-c3ccccc3)c2C1.O=C(NCc1ccnnc1)N1CCc2[nH]nc(-c3ccccc3)c2C1.O=C(NCc1cncnc1)N1CCc2[nH]nc(-c3ccccc3)c2C1.O=C(NCc1ncccn1)N1CCc2[nH]nc(-c3ccccc3)c2C1 |
| InChI | InChI=1S/C20H21N5O2.4C18H18N6O/c1-24-12-14(7-8-18(24)26)11-21-20(27)25-10-9-17-16(13-25)19(23-22-17)15-5-3-2-4-6-15;25-18(21-11-16-19-8-4-9-20-16)24-10-7-15-14(12-24)17(23-22-15)13-5-2-1-3-6-13;25-18(19-11-14-7-4-9-20-21-14)24-10-8-16-15(12-24)17(23-22-16)13-5-2-1-3-6-13;25-18(19-10-13-6-8-20-21-11-13)24-9-7-16-15(12-24)17(23-22-16)14-4-2-1-3-5-14;25-18(21-10-13-8-19-12-20-9-13)24-7-6-16-15(11-24)17(23-22-16)14-4-2-1-3-5-14/h2-8,12H,9-11,13H2,1H3,(H,21,27)(H,22,23);1-6,8-9H,7,10-12H2,(H,21,25)(H,22,23);1-7,9H,8,10-12H2,(H,19,25)(H,22,23);1-6,8,11H,7,9-10,12H2,(H,19,25)(H,22,23);1-5,8-9,12H,6-7,10-11H2,(H,21,25)(H,22,23) |
| InChIKey | HMJIBUPUTDORLY-UHFFFAOYSA-N |
| XLogP | 10.58 |
| TPSA | 430.22 Ų |
| H-Bond Donors | 10 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 127 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1700.95 |
| LogP ≤ 5 | 10.58 |
| H-Bond Donors ≤ 5 | 10 |
| H-Bond Acceptors ≤ 10 | 20 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158522382 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.